Skip to main content

Table 4 Summary of the final results*

From: Cost-utility analysis of propranolol versus corticosteroids in the treatment of proliferating infantile hemangioma in Italy

  Propranolol Corticosteroids
Base case p 2,5 p 97,5 Base case p 2,5 p 97,5
Pharmaceutical costs €1,405.03 €1,350.23 €1,453.47 €17.56 €16.88 €18.14
Healthcare costs €994.29 €709.01 €1,320.26 €1,842.12 €1,432.84 €2,082.19
Total costs €2,399.32 €2,059.24 €2,773.73 €1,859.68 €1,449.72 €2,100.33
Total QALYs 19.11 18.80 19.47 18.95 18.60 19.33
  Base case p 2,5 p 97,5
ICUR €3,372.75/QALY €3,047.60/QALY €4.810.00/QALY
  1. *The results were based on 30 year lifetime and 3% of discount rate for both costs and benefits